Clinical Features of Bim Deletion Polymorphism and Its Relation with Crizotinib Primary Resistance in Chinese Patients with Alk/Ros1 Fusion-Positive Non-Small Cell Lung Cancer
Cancer（2017）
Key words
anaplastic lymphoma kinase (ALK),B-cell chronic lymphocytic leukemia/lymphoma (Bcl-2)-like 11 (BCL2L11) (Bim),crizotinib,non-small cell lung cancer,ROS proto-oncogene 1,receptor tyrosine kinase (ROS1)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined